MedTrace Logo

Glucosamine Sulphate, Ginger, Ginger-Avocado-Soya and Ginger-Ibuprofen for Chronic Back Pain

NCT00317655 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 175

Last updated 2007-05-17

No results posted yet for this study

Summary

The main purpose of this study is to investigate the ability of some dietary supplement products to affect general joint health and life quality in a selected population with back pain.

The study is randomized and double - blind, with parallel groups receiving treatment for a duration of 12 weeks.

Conditions

Interventions

DRUG

Glucosamine sulphate

DRUG

Ginger

DRUG

Ginger-Avocado-Soya

DRUG

Ginger-ibuprofen

Sponsors & Collaborators

  • Ferrosan AS

    lead INDUSTRY

Principal Investigators

  • Keld Østergaard, MD, PhD · Slidgigtinstituttet A/S

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-04-30
Completion
2007-04-30

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00317655 on ClinicalTrials.gov